CS Elite Fastpack, 225 mL, 150 Res Autotransfusion Device - Product Usage: its related accessory components are intended for use to recover blood shed during or subsequent to an operation or as a result of trauma, processing the blood by a centrifugation and washing procedure, and pumping this processed red cell product to either a bag for gravity reinfusion into the patient or to the arterial line of an extracorporeal circuit for reinfusion into the patient.
Publicado el 5 de febrero de 2020 · Inicio del retiro: 21 de octubre de 2019
Resumen
FDA registra el retiro Z-0895-2020 de dispositivos médicos de Clase II, publicado el 5 de febrero de 2020 e iniciado el 21 de octubre de 2019. Empresa responsable: Haemonetics Corporation; Estado: Finalizado; Cantidad reportada: 42739; Lote: Catalog number/FG Item Number: CSE-FP-225V 1. Specific Lots with Bowl Cracks (7636 Distributed) Lot number: 1902009HTT 1903001HTT 1903004HTT 1804008HTT 1804010HTT 1805004HTT 1805005HTT 1812012HTT 1901004HTT 1901005HTT 1901006HTT 1808007HTT 1808009HTT 1808012HTT 1809001HTT 1809002HTT 1809006HTT 1809009HTT 1810001HTT 1810003HTT 1901005HTT 1902009HTT 1810006HTT 2. Missing instructions to check for cracks in IFU All products/lost manufactured between October 2014 and October 2019. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Potential to develop leaks at the inner core of Cell Saver® 5/5+ and Cell Saver® Elite®/Elite® +125ml and 225ml bowl sets. Which could result in fluid being trapped inside the bowl core, causing a long empty device error message with the possibility of incomplete washing.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Haemonetics Corporation
- Distribuidor
- Worldwide distribution - US Nationwide distribution in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, and countries of NZ, AU, IN, PK, PH, HK, VN, MY, ID, SG, CN, AT, DE, FR, GB, IT, CH.
- Lote
- Catalog number/FG Item Number: CSE-FP-225V 1. Specific Lots with Bowl Cracks (7636 Distributed) Lot number: 1902009HTT 1903001HTT 1903004HTT 1804008HTT 1804010HTT 1805004HTT 1805005HTT 1812012HTT 1901004HTT 1901005HTT 1901006HTT 1808007HTT 1808009HTT 1808012HTT 1809001HTT 1809002HTT 1809006HTT 1809009HTT 1810001HTT 1810003HTT 1901005HTT 1902009HTT 1810006HTT 2. Missing instructions to check for cracks in IFU All products/lost manufactured between October 2014 and October 2019.
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDACS5/5+ Fastpacks, 225 mL, 20® Res Autotransfusion Device - Product Usage: its related accessory components are5 de febrero de 2020
- FDAJapan DISP SET, 263J, 205J, HAR - Product Usage: its related accessory components are intended to be used for5 de febrero de 2020
- FDACS5/5+ Fastpacks, 125 mL, 20® Res Autotransfusion Device- Product Usage: its related accessory components are5 de febrero de 2020
- FDAJAPAN CELL SAVER ELITE SET - 225ML - Product Usage: its related accessory components are intended for use to5 de febrero de 2020
- FDAJAPAN DISP SET, 261J, 205J, HAR - Product Usage: its related accessory components are intended to be used for5 de febrero de 2020
- FDA2.4MM TI VA LOCKING SCREW STARDRIVE 18MM STERILE, Part Number 04.210.118TS - Product Usage:Sterile Tube5 de febrero de 2020
Preguntas sobre este retiro
¿CS Elite Fastpack, 225 mL, 150 Res Autotransfusion Device - Product Usage: its related accessory components are intended for use to recover blood shed during or subsequent to an operation or as a result of trauma, processing the blood by a centrifugation and washing procedure, and pumping this processed red cell product to either a bag for gravity reinfusion into the patient or to the arterial line of an extracorporeal circuit for reinfusion into the patient. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0895-2020 el 5 de febrero de 2020. Peligro reportado: Potential to develop leaks at the inner core of Cell Saver® 5/5+ and Cell Saver® Elite®/Elite® +125ml and 225ml bowl sets. Which could result in fluid being trapped inside the bowl core, causing a long empty device error message with the possibility of incomplete washing.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter